These results show that the growth factor-mediated hMena protein upregulation reported previously [15], [16] is related to an increase in hMena mRNA and indicate that HER2 overexpression and activity contribute to hMena/hMena11a overexpression in BC cell lines. This evidence concerns the gene ERBB2 and breast cancer.